Showing results (61-70 of 164) with videos related to
Sort By:
Pageof 17
Life Sciences|June 4, 2019
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevanceMasoud Najafi, Keywan Mortezaee, Reza AhadiJournal of Cellular Physiology|December 7, 2018
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A reviewBagher Farhood, Masoud Najafi, Keywan MortezaeeBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2023
The impact of hypoxia on tumor-mediated bypassing anti-PD-(L)1 therapyKeywan Mortezaee, Jamal Majidpoor, Ebrahim KharazinejadLife Sciences|August 21, 2019
Cancer stem cell (CSC) resistance driversMasoud Najafi, Keywan Mortezaee, Jamal MajidpoorLife Sciences|November 16, 2019
Stromal reprogramming: A target for tumor therapyMasoud Najafi, Keywan Mortezaee, Jamal MajidpoorJournal of Cellular Physiology|November 13, 2018
Cancer stem cells (CSCs) in cancer progression and therapyMasoud Najafi, Bagher Farhood, Keywan MortezaeeExpert Reviews in Molecular Medicine|October 21, 2022
Extracellular vesicle isolation, purification and evaluation in cancer diagnosisKeywan Mortezaee, Jamal Majidpoor, Fardin FathiCell Biology International|May 29, 2019
Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated reviewMasoud Najafi, Amirhossein Ahmadi, Keywan MortezaeeBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 25, 2023
The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockadeSajad Najafi, Jamal Majidpoor, Keywan MortezaeePathology, Research and Practice|June 2, 2023
The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4Sasan Parvini, Jamal Majidpoor, Keywan MortezaeePageof 17